Symphony Biosciences
The startup develops biomaterial-based cancer drugs specifically targeting solid tumors, enhancing treatment efficacy while minimizing adverse effects. By improving survival rates, the company provides healthcare professionals with new therapeutic options for patients facing challenging cancer diagnoses.
- Biotechnology
Updated 23 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops biomaterial-based cancer drugs specifically targeting solid tumors, enhancing treatment efficacy while minimizing adverse effects. By improving survival rates, the company provides healthcare professionals with new therapeutic options for patients facing challenging cancer diagnoses.